• EL - ελληνικά
  • EN - English
Parliamentary question - E-005527/2016Parliamentary question
E-005527/2016

Cost of hospital care for refugees and migrants and the situation regarding pharmaceutical companies

Question for written answer E-005527-16
to the Commission
Rule 130
Georgios Kyrtsos (PPE) , Elissavet Vozemberg-Vrionidi (PPE)

Greece is the principal beneficiary of aid from the Asylum, Migration and Integration Fund (AMIF) and the Internal Security Fund (ISF), amounting to around EUR 509 million for the period 2014-2020.

However, at the end of June 2016, pre-financing of EUR 70 million had, according to the Commission, remained unused by Greece.

In addition to this delay, Greek public hospitals are now, in the necessary spirit of solidarity, providing medical care for thousands of migrants and refugees, the cost of which is being met by Greek taxpayers and by pharmaceutical companies, which are required to pay excessive amounts under the agreed claw-back provisions.

In view of this: